Latest FULC reports update at 2024-05-13: 2024-Q12023-Q42023-Q1
Fulcrum Therapeutics logo
Fulcrum Therapeutics FULC
$ 5.93 -3.66%

Fulcrum Therapeutics Deferred Revenue 2011-2024 | FULC

Annual Deferred Revenue Fulcrum Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- 934 K 4.71 M 14.9 M 3.99 M - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
14.9 M 934 K 6.14 M

Quarterly Deferred Revenue Fulcrum Therapeutics

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - 334 K 513 K 737 K 934 K 1.39 M 1.78 M 2.92 M 4.71 M 6.13 M 9.9 M 12.1 M 14.9 M 14.9 M 14.9 M 14.9 M 3.99 M - 3.99 M 3.99 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
14.9 M 334 K 6.28 M